Issue 6, 2025

Advances of dual-organ and multi-organ systems for gut, lung, skin and liver models in absorption and metabolism studies

Abstract

Drug development is a costly and timely process with high risks of failure during clinical trials. Although in vitro tissue models have significantly advanced over the years, thus fostering a transition from animal-derived models towards human-derived models, failure rates still remain high. Current cell-based assays are still not able to provide an accurate prediction of the clinical success or failure of a drug candidate. To overcome the limitations of current methods, a variety of microfluidic systems have been developed as powerful tools that are capable of mimicking (micro)physiological conditions more closely by integrating physiological fluid flow conditions, mechanobiological cues and concentration gradients, to name only a few. One major advantage of these biochip-based tissue cultures, however, is their ability to seamlessly connect different organ models, thereby allowing the study of organ-crosstalk and metabolic byproduct effects. This is especially important when assessing absorption, distribution, metabolism, and excretion (ADME) processes of drug candidates, where an interplay between various organs is a prerequisite. In the current review, a number of in vitro models as well as microfluidic dual- and multi-organ systems are summarized with a focus on absorption (skin, lung, gut) and metabolism (liver). Additionally, the advantage of multi-organ chips in identifying a drug's on and off-target toxicity is discussed. Finally, the potential high-throughput implementation and modular chip design of multi-organ-on-a-chip systems within the pharmaceutical industry is highlighted, outlining the necessity of reducing handling complexity.

Graphical abstract: Advances of dual-organ and multi-organ systems for gut, lung, skin and liver models in absorption and metabolism studies

Article information

Article type
Tutorial Review
Submitted
29 Nov 2024
Accepted
07 Feb 2025
First published
13 Feb 2025
This article is Open Access
Creative Commons BY license

Lab Chip, 2025,25, 1384-1403

Advances of dual-organ and multi-organ systems for gut, lung, skin and liver models in absorption and metabolism studies

K. Brandauer, S. Schweinitzer, A. Lorenz, J. Krauß, S. Schobesberger, M. Frauenlob and P. Ertl, Lab Chip, 2025, 25, 1384 DOI: 10.1039/D4LC01011F

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements